Logo image of ZIL2.DE

ELRINGKLINGER AG (ZIL2.DE) Stock Fundamental Analysis

FRA:ZIL2 - Deutsche Boerse Ag - DE0007856023 - Common Stock - Currency: EUR

4.505  -0.17 (-3.74%)

Fundamental Rating

3

Overall ZIL2 gets a fundamental rating of 3 out of 10. We evaluated ZIL2 against 31 industry peers in the Automobile Components industry. ZIL2 has a bad profitability rating. Also its financial health evaluation is rather negative. ZIL2 does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ZIL2 has reported negative net income.
ZIL2 had a positive operating cash flow in the past year.
In multiple years ZIL2 reported negative net income over the last 5 years.
ZIL2 had a positive operating cash flow in each of the past 5 years.
ZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

ZIL2 has a Return On Assets (-0.54%) which is in line with its industry peers.
ZIL2 has a Return On Equity (-1.34%) which is comparable to the rest of the industry.
The Return On Invested Capital of ZIL2 (1.33%) is worse than 77.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ZIL2 is below the industry average of 6.15%.
Industry RankSector Rank
ROA -0.54%
ROE -1.34%
ROIC 1.33%
ROA(3y)0.09%
ROA(5y)-0.32%
ROE(3y)0%
ROE(5y)-0.95%
ROIC(3y)3.61%
ROIC(5y)2.92%
ZIL2.DE Yearly ROA, ROE, ROICZIL2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

In the last couple of years the Profit Margin of ZIL2 has declined.
ZIL2 has a worse Operating Margin (1.66%) than 74.19% of its industry peers.
In the last couple of years the Operating Margin of ZIL2 has declined.
ZIL2's Gross Margin of 23.57% is in line compared to the rest of the industry. ZIL2 outperforms 45.16% of its industry peers.
ZIL2's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.66%
PM (TTM) N/A
GM 23.57%
OM growth 3Y32.29%
OM growth 5Y-2.22%
PM growth 3YN/A
PM growth 5Y-3.78%
GM growth 3Y4.25%
GM growth 5Y0.02%
ZIL2.DE Yearly Profit, Operating, Gross MarginsZIL2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

ZIL2 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ZIL2 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ZIL2 remains at a similar level compared to 5 years ago.
The debt/assets ratio for ZIL2 has been reduced compared to a year ago.
ZIL2.DE Yearly Shares OutstandingZIL2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ZIL2.DE Yearly Total Debt VS Total AssetsZIL2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

ZIL2 has an Altman-Z score of 1.75. This is a bad value and indicates that ZIL2 is not financially healthy and even has some risk of bankruptcy.
ZIL2 has a Altman-Z score (1.75) which is in line with its industry peers.
The Debt to FCF ratio of ZIL2 is 36.84, which is on the high side as it means it would take ZIL2, 36.84 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 36.84, ZIL2 is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.38 indicates that ZIL2 is not too dependend on debt financing.
ZIL2 has a better Debt to Equity ratio (0.38) than 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 36.84
Altman-Z 1.75
ROIC/WACC0.28
WACC4.73%
ZIL2.DE Yearly LT Debt VS Equity VS FCFZIL2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.54 indicates that ZIL2 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.54, ZIL2 is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that ZIL2 may have some problems paying its short term obligations.
ZIL2's Quick ratio of 0.77 is on the low side compared to the rest of the industry. ZIL2 is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.77
ZIL2.DE Yearly Current Assets VS Current LiabilitesZIL2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ZIL2 have decreased strongly by -172.38% in the last year.
Measured over the past years, ZIL2 shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.15% on average per year.
The Revenue has decreased by -4.64% in the past year.
Measured over the past years, ZIL2 shows a small growth in Revenue. The Revenue has been growing by 1.69% on average per year.
EPS 1Y (TTM)-172.38%
EPS 3YN/A
EPS 5Y-2.15%
EPS Q2Q%-824.35%
Revenue 1Y (TTM)-4.64%
Revenue growth 3Y7.66%
Revenue growth 5Y1.69%
Sales Q2Q%-2.4%

3.2 Future

ZIL2 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.57% yearly.
Based on estimates for the next years, ZIL2 will show a small growth in Revenue. The Revenue will grow by 0.32% on average per year.
EPS Next Y-159.05%
EPS Next 2Y13.39%
EPS Next 3Y22.57%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y-2.63%
Revenue Next 3Y-0.37%
Revenue Next 5Y0.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZIL2.DE Yearly Revenue VS EstimatesZIL2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ZIL2.DE Yearly EPS VS EstimatesZIL2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZIL2. In the last year negative earnings were reported.
ZIL2 is valuated cheaply with a Price/Forward Earnings ratio of 6.54.
Based on the Price/Forward Earnings ratio, ZIL2 is valued a bit cheaper than 70.97% of the companies in the same industry.
ZIL2 is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.54
ZIL2.DE Price Earnings VS Forward Price EarningsZIL2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZIL2 is valued a bit cheaper than the industry average as 77.42% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZIL2 indicates a slightly more expensive valuation: ZIL2 is more expensive than 67.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.36
EV/EBITDA 2.91
ZIL2.DE Per share dataZIL2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as ZIL2's earnings are expected to grow with 22.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.39%
EPS Next 3Y22.57%

More info and screens

4

5. Dividend

5.1 Amount

ZIL2 has a Yearly Dividend Yield of 3.64%.
Compared to an average industry Dividend Yield of 5.33, ZIL2 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, ZIL2 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.64%

5.2 History

The dividend of ZIL2 decreases each year by -23.34%.
Dividend Growth(5Y)-23.34%
Div Incr Years0
Div Non Decr Years2
ZIL2.DE Yearly Dividends per shareZIL2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

39.86% of the earnings are spent on dividend by ZIL2. This is a low number and sustainable payout ratio.
DP39.86%
EPS Next 2Y13.39%
EPS Next 3Y22.57%
ZIL2.DE Yearly Income VS Free CF VS DividendZIL2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M
ZIL2.DE Dividend Payout.ZIL2.DE Dividend Payout, showing the Payout Ratio.ZIL2.DE Dividend Payout.PayoutRetained Earnings

More info and screens

ELRINGKLINGER AG

FRA:ZIL2 (3/21/2025, 7:00:00 PM)

4.505

-0.17 (-3.74%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-12 2024-11-12
Earnings (Next)03-27 2025-03-27/amc
Inst Owners3.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap285.44M
Analysts73.85
Price Target5.48 (21.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.64%
Yearly Dividend0.15
Dividend Growth(5Y)-23.34%
DP39.86%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-145.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-1.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.54
P/S 0.16
P/FCF 26.36
P/OCF 2.38
P/B 0.36
P/tB 0.47
EV/EBITDA 2.91
EPS(TTM)-0.17
EYN/A
EPS(NY)0.69
Fwd EY15.28%
FCF(TTM)0.17
FCFY3.79%
OCF(TTM)1.89
OCFY41.95%
SpS28.25
BVpS12.41
TBVpS9.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -1.34%
ROCE 2.12%
ROIC 1.33%
ROICexc 1.41%
ROICexgc 1.63%
OM 1.66%
PM (TTM) N/A
GM 23.57%
FCFM 0.6%
ROA(3y)0.09%
ROA(5y)-0.32%
ROE(3y)0%
ROE(5y)-0.95%
ROIC(3y)3.61%
ROIC(5y)2.92%
ROICexc(3y)3.97%
ROICexc(5y)3.21%
ROICexgc(3y)4.58%
ROICexgc(5y)3.72%
ROCE(3y)5.89%
ROCE(5y)4.75%
ROICexcg growth 3Y43.12%
ROICexcg growth 5Y5.51%
ROICexc growth 3Y44.24%
ROICexc growth 5Y5.06%
OM growth 3Y32.29%
OM growth 5Y-2.22%
PM growth 3YN/A
PM growth 5Y-3.78%
GM growth 3Y4.25%
GM growth 5Y0.02%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 36.84
Debt/EBITDA 1.44
Cap/Depr 61.09%
Cap/Sales 6.08%
Interest Coverage 1.17
Cash Conversion 57.55%
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 0.77
Altman-Z 1.75
F-Score4
WACC4.73%
ROIC/WACC0.28
Cap/Depr(3y)67.07%
Cap/Depr(5y)68.08%
Cap/Sales(3y)5.29%
Cap/Sales(5y)5.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-172.38%
EPS 3YN/A
EPS 5Y-2.15%
EPS Q2Q%-824.35%
EPS Next Y-159.05%
EPS Next 2Y13.39%
EPS Next 3Y22.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.64%
Revenue growth 3Y7.66%
Revenue growth 5Y1.69%
Sales Q2Q%-2.4%
Revenue Next Year-3.12%
Revenue Next 2Y-2.63%
Revenue Next 3Y-0.37%
Revenue Next 5Y0.32%
EBIT growth 1Y-65.68%
EBIT growth 3Y42.42%
EBIT growth 5Y-0.57%
EBIT Next Year102.65%
EBIT Next 3Y40.14%
EBIT Next 5YN/A
FCF growth 1Y131.83%
FCF growth 3Y-40.62%
FCF growth 5YN/A
OCF growth 1Y73.04%
OCF growth 3Y-15.87%
OCF growth 5Y7.21%